Pangaea Ventures participated in a $20 million Series B1 funding round for Membrion, a company innovating in wastewater treatment technology to address global water scarcity challenges.
Information on the Target
Membrion is at the forefront of innovation in water treatment technology, specializing in advanced materials science to tackle the critical issue of wastewater management. This emerging company has developed electro-ceramic desalination units that efficiently treat challenging industrial waste streams, particularly in sectors such as semiconductors, mining, and metal plating. By effectively removing problematic ions and achieving high selectivity, Membrion is poised to transform how industries approach water reuse and sustainability.
The company's patented technology, which surpasses the limitations of traditional reverse osmosis systems, demonstrates notable durability even under harsh conditions often experienced in semiconductor fabs. As water scarcity becomes a pressing global issue, Membrion’s solutions offer a pathway towards sustainable resource recovery and improved regulatory compliance for industrial end-users worldwide.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The global water treatment market is undergoing significant growth, driven predominantly by increasing environmental regulations and the urgent need to address water scarcity. As of 2022, the wastewater treatment services market was valued at approximately $
Similar Deals
Marker Hill Capital, Constellation Technology Ventures, Southwire Company, RightHill Ventures, Clean Energy Venture Group → VoltServer
2023
Not Disclosed → Aqua Membranes
2023
Renewal Funds → Olea Edge Analytics
2020
Pangaea Ventures
invested in
Membrion
in
in a Series B deal
Disclosed details
Transaction Size: $20M